IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-04-28 (managedhealthcareexecutive.com)
Luke Greenwalt, MBA, on the Current Market Conditions for New Drug Launches | Asembia's AXS25 Summit
The vice president and lead of IQVIA's Market Access Center of Excellence says fewer drugs are hitting the $100 million mark during their first year on the market than in the past.
Read more
2025-04-10 (geekpark.net)
Sandalwood Rosewood Data and IQVIA jointly release China OTC market trend report to help pharmaceutical companies seize new retail growth opportunities | Geek Park
April 8 - 12, 2025, Wuzhen, China - The 2025 Wuzhen Health Conference was held with the theme of "To Spring·Endogenicity and Exogenous In Changes".
Read more
2025-01-05 (benzinga.com)
How Is The Market Feeling About IQVIA Hldgs? - IQVIA Hldgs (NYSE:IQV) -
IQVIA Hldgs's IQV short percent of float has fallen 9.69% since its last report. The company recently reported that it has 2.81 million shares sold short, which is 1.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their short positions on average.
Read more
2024-11-06 (revuepharma.fr)
The painkillers match
Focus on the analgesics market by IQVIA France.
Read more
2024-10-31 (immedicohospitalario.es)
The otorhinolaryngology market continues to experience new growth
Otological medications keep the growth wave high in otorhinolaryngology through a strong demand for anti-infectives, different types of corticosteroids and other preparations indicated to treat ear conditions since, as the figures provided by the firm IQVIA show, this
Read more
2024-09-25 (revuepharma.fr)
The infant milk market by IQVIA
Focus on the infant milk market in pharmacies by IQVIA France
Read more
2024-05-22 (drugstorenews.com)
Hikma enters Spanish generic injectables market
In the year to date, Hikma has received 36 product approvals and launched 25 products in Spain.
Read more
2024-04-10 (financialexpress.com)
Lupin launches generic formulation of bacterial pneumonia drug in United States
Doxycycline Capsules had estimated annual sales of $128 million in the U.S. (IQVIA MAT February 2024).
Read more
2024-02-16 (financialexpress.com)
Lupin launches infertility treatment injection in United States
Ganirelix Acetate Injection had estimated annual sales of USD 87 million in the U.S. (IQVIA MAT December 2023).
Read more
2024-02-16 (financialexpress.com)
Lupin launches infertility treatment injection in United States
Ganirelix Acetate Injection had estimated annual sales of USD 87 million in the U.S. (IQVIA MAT December 2023).
Read more
2024-01-24 (nutraingredients.com)
Nutraceutical market trends for 2024: insights by PharmaLinea and IQVIA
We will examine how supplements developed in 2023 and indicate what trends can be expected in the future. Register to get an overview of the market and ideas on how to succeed in the coming years.
Read more
2023-10-03 (spotandweb.it)
Pfizer launches initiative to raise awareness of sexuality and metastatic breast cancer - Spot and Web
Today in Italy there are approximately 37,000 women living with metastatic breast cancer. Women who face complex paths, each with different nuances and situations. They have many aspects in common, one is represented by the psychological and physiological problems that pertain to the sphere
Read more